2021
DOI: 10.1667/rade-20-00206.1
|View full text |Cite
|
Sign up to set email alerts
|

GDF15 Promotes Cardiac Fibrosis and Proliferation of Cardiac Fibroblasts via the MAPK/ERK1/2 Pathway after Irradiation in Rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 14 publications
(6 citation statements)
references
References 24 publications
1
5
0
Order By: Relevance
“…In addition, decreased growth and activation of lung fibroblasts due to GDF15-associated alterations in the TGF-Smad pathway have been described [ 59 ]. Contrarily, Guo et al recently revealed that GDF15 can promote proliferation in newborn rat cardiac fibroblasts after irradiation, which was confirmed by the increased cell proliferation rate and increased expression of fibrosis markers (Col1α and αSma) after transfection with GDF15 in vitro [ 60 ]. However, our data support an antiproliferative effect of GDF15, specifically on hPdLFs, in terms of decreased Ki67, whereas we could not detect an impact on the apoptosis rate of hPdLFs.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, decreased growth and activation of lung fibroblasts due to GDF15-associated alterations in the TGF-Smad pathway have been described [ 59 ]. Contrarily, Guo et al recently revealed that GDF15 can promote proliferation in newborn rat cardiac fibroblasts after irradiation, which was confirmed by the increased cell proliferation rate and increased expression of fibrosis markers (Col1α and αSma) after transfection with GDF15 in vitro [ 60 ]. However, our data support an antiproliferative effect of GDF15, specifically on hPdLFs, in terms of decreased Ki67, whereas we could not detect an impact on the apoptosis rate of hPdLFs.…”
Section: Discussionmentioning
confidence: 99%
“…Among them, mediators related to cardiac fibrosis include transforming growth factor- β (TGF- β ) and platelet-derived growth factor [ 7 ]. Although more and more researchers have made great efforts to slow the progression of cardiac fibrosis, the molecular mechanism has not been clarified yet [ 8 ]. Further exploration and research on the containment of cardiac fibrosis are of great significance for the cognition, prevention, and treatment of cardiac fibrosis-related diseases.…”
Section: Introductionmentioning
confidence: 99%
“…The expressions of α‐SMA (also known as a marker for activated VICs 25 ) and connective tissue growth factor (CTGF; involved in valvular fibrosis 26 ) were significantly upregulated in DKO valves at 2 months old (Figure 7B and 7C ). Additionally, growth differentiation factor‐15 (Gdf15), which belongs to the TGF‐β superfamily and has recently been shown to increase in cardiac fibrosis, 27 was increased in the DKO valves (Figure 7D ). These results indicate that Fbln4 deficiency in ECs may induce EndMT to generate activated VICs and cause valvular thickening and fibrosis, which subsequently promotes TAAs.…”
Section: Resultsmentioning
confidence: 98%